The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.

IF 12.5 2区 医学 Q1 SURGERY
Lilong Liu, Kaiwen Li, Shao-Gang Wang, Jianli Wang, Zhipeng Yao, Yu Xie, Zhigang Ji, Zhiwen Chen, Hailong Hu, Haige Chen, Junyi Hu, Yaxin Hou, Zhenghao Liu, Yang Li, Yuhong Ding, Yingchun Kuang, Yang Xun, Jia Hu, Jiaqiao Zhang, Heng Li, Tie Chong, Jianbin Bi, Zhiping Wang, Yinhuai Wang, Peng Zhang, Qiang Wei, Zhaohui Chen, Lei Li, Jian Huang, Zheng Liu, Ke Chen
{"title":"The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.","authors":"Lilong Liu, Kaiwen Li, Shao-Gang Wang, Jianli Wang, Zhipeng Yao, Yu Xie, Zhigang Ji, Zhiwen Chen, Hailong Hu, Haige Chen, Junyi Hu, Yaxin Hou, Zhenghao Liu, Yang Li, Yuhong Ding, Yingchun Kuang, Yang Xun, Jia Hu, Jiaqiao Zhang, Heng Li, Tie Chong, Jianbin Bi, Zhiping Wang, Yinhuai Wang, Peng Zhang, Qiang Wei, Zhaohui Chen, Lei Li, Jian Huang, Zheng Liu, Ke Chen","doi":"10.1097/JS9.0000000000001675","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Most bladder cancers are nonmuscle invasive bladder cancer (NMIBC), and transurethral resection of bladder tumors (TURBT) is the standard treatment. However, postoperative recurrence remains a significant challenge, and the influence of bladder tumor location on prognosis is still unclear. This study aims to investigate how tumor location affects the prognosis of NMIBC patients undergoing TURBT and to identify the optimal surgical approach.</p><p><strong>Methods: </strong>A multicenter study was conducted, which included Chinese NMIBC data from 15 hospitals (1996-2019) and data from 17 registries of the Surveillance, Epidemiology, and End Results database (SEER) (2000-2020). Patients initially diagnosed with NMIBC and undergoing TURBT or partial cystectomy were analyzed, with cases lost to follow-up or with missing data excluded. The study investigated the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) among patients with different tumor locations. Kaplan-Meier, Cox regression, and propensity score matching methods were employed to explore the association between tumor location and prognosis. Stratified populations were analyzed to minimize bias.</p><p><strong>Results: </strong>This study included 118 477 NMIBC patients and highlighted tumor location as a crucial factor impacting post-TURBT prognosis. Both anterior wall and dome tumors independently predicted adverse outcomes in two cohorts. For anterior wall tumors, the Chinese cohort showed hazard ratios (HR) for OS of 4.35 ( P <0.0001); RFS of 2.21 ( P <0.0001); SEER cohort OS HR of 1.10 ( P =0.0001); DSS HR of 1.13 ( P =0.0183). Dome tumors displayed similar trends [Chinese NMIBC cohort OS HR of 7.91 ( P <0.0001); RFS HR of 2.12 ( P <0.0001); SEER OS HR of 1.05 ( P =0.0087); DSS HR of 1.14 ( P =0.0006)]. Partial cystectomy significantly improved the survival of dome tumor patients compared to standard TURBT treatment ( P <0.01).</p><p><strong>Conclusion: </strong>This study reveals the significant impact of tumor location in NMIBC patients on the outcomes of TURBT treatment, with tumors in the anterior wall and bladder dome showing poor post-TURBT prognosis. Compared to TURBT treatment, partial cystectomy improves the prognosis for bladder dome tumors. This study provides guidance for personalized treatment and prognosis management for NMIBC patients.</p>","PeriodicalId":14401,"journal":{"name":"International journal of surgery","volume":" ","pages":"5641-5651"},"PeriodicalIF":12.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11392199/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JS9.0000000000001675","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Most bladder cancers are nonmuscle invasive bladder cancer (NMIBC), and transurethral resection of bladder tumors (TURBT) is the standard treatment. However, postoperative recurrence remains a significant challenge, and the influence of bladder tumor location on prognosis is still unclear. This study aims to investigate how tumor location affects the prognosis of NMIBC patients undergoing TURBT and to identify the optimal surgical approach.

Methods: A multicenter study was conducted, which included Chinese NMIBC data from 15 hospitals (1996-2019) and data from 17 registries of the Surveillance, Epidemiology, and End Results database (SEER) (2000-2020). Patients initially diagnosed with NMIBC and undergoing TURBT or partial cystectomy were analyzed, with cases lost to follow-up or with missing data excluded. The study investigated the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) among patients with different tumor locations. Kaplan-Meier, Cox regression, and propensity score matching methods were employed to explore the association between tumor location and prognosis. Stratified populations were analyzed to minimize bias.

Results: This study included 118 477 NMIBC patients and highlighted tumor location as a crucial factor impacting post-TURBT prognosis. Both anterior wall and dome tumors independently predicted adverse outcomes in two cohorts. For anterior wall tumors, the Chinese cohort showed hazard ratios (HR) for OS of 4.35 ( P <0.0001); RFS of 2.21 ( P <0.0001); SEER cohort OS HR of 1.10 ( P =0.0001); DSS HR of 1.13 ( P =0.0183). Dome tumors displayed similar trends [Chinese NMIBC cohort OS HR of 7.91 ( P <0.0001); RFS HR of 2.12 ( P <0.0001); SEER OS HR of 1.05 ( P =0.0087); DSS HR of 1.14 ( P =0.0006)]. Partial cystectomy significantly improved the survival of dome tumor patients compared to standard TURBT treatment ( P <0.01).

Conclusion: This study reveals the significant impact of tumor location in NMIBC patients on the outcomes of TURBT treatment, with tumors in the anterior wall and bladder dome showing poor post-TURBT prognosis. Compared to TURBT treatment, partial cystectomy improves the prognosis for bladder dome tumors. This study provides guidance for personalized treatment and prognosis management for NMIBC patients.

接受经尿道切除术的非肌层浸润性膀胱癌患者肿瘤位置对预后的影响:利用中国多中心和 SEER 登记进行的队列研究的启示。
目的:大多数膀胱癌属于非肌层浸润性膀胱癌(NMIBC),经尿道膀胱肿瘤切除术(TURBT)是标准治疗方法。然而,术后复发仍是一个重大挑战,膀胱肿瘤位置对预后的影响仍不明确。本研究旨在探讨肿瘤位置如何影响接受 TURBT 治疗的 NMIBC 患者的预后,并确定最佳手术方法:这项多中心研究纳入了来自 15 家医院(1996-2019 年)的中国 NMIBC 数据和来自监测、流行病学和最终结果数据库(SEER)17 个登记处(2000-2020 年)的数据。研究分析了初步诊断为NMIBC并接受TURBT或部分膀胱切除术的患者,并排除了失去随访或数据缺失的病例。研究调查了不同肿瘤位置患者的总生存期(OS)、疾病特异性生存期(DSS)和无复发生存期(RFS)。研究采用卡普兰-梅耶(Kaplan-Meier)、考克斯回归(Cox regression)和倾向得分匹配法来探讨肿瘤位置与预后之间的关系。对分层人群进行了分析,以尽量减少偏差:这项研究纳入了 118,477 例 NMIBC 患者,并强调肿瘤位置是影响 TURBT 术后预后的关键因素。在两个队列中,前壁肿瘤和穹隆肿瘤均可独立预测不良预后。对于前壁肿瘤,中国队列的OS危险比(HR)为4.35(P < 0.0001);RFS为2.21(P < 0.0001);SEER队列的OS危险比为1.10(P = 0.0001);DSS危险比为1.13(P = 0.0183)。穹隆瘤显示出相似的趋势(中国NMIBC队列OS HR为7.91(P<0.0001);RFS HR为2.12(P<0.0001);SEER OS HR为1.05(P=0.0087);DSS HR为1.14(P=0.0006))。与标准TURBT治疗相比,膀胱部分切除术明显提高了穹隆瘤患者的生存率(P < 0.01):本研究揭示了肿瘤位置对NMIBC患者TURBT治疗效果的重要影响,前壁和膀胱穹隆肿瘤的TURBT术后预后较差。与 TURBT 治疗相比,膀胱部分切除术可改善膀胱穹隆肿瘤的预后。这项研究为NMIBC患者的个性化治疗和预后管理提供了指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
17.70
自引率
3.30%
发文量
0
审稿时长
6-12 weeks
期刊介绍: The International Journal of Surgery (IJS) has a broad scope, encompassing all surgical specialties. Its primary objective is to facilitate the exchange of crucial ideas and lines of thought between and across these specialties.By doing so, the journal aims to counter the growing trend of increasing sub-specialization, which can result in "tunnel-vision" and the isolation of significant surgical advancements within specific specialties.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信